Biochemical Pharmacology volume 80, issue 1, P62-71 2010 DOI: 10.1016/j.bcp.2010.03.008 View full text
|
|
Share
Dinesh Thapa, Dinesh Babu, Min-A. Park, Mi-Kyoung Kwak, Yong-Rok Lee, Jeong Min Kim, Taeg Kyu Kwon, Jung-Ae Kim

Abstract: Nonsteroidal anti-inflammatory drug (NSAID)-activated gene-1 (NAG-1) has received greater attention as a novel molecular target for anti-cancer therapeutics in recent years. We identified a novel synthetic hexahydrocannabinol analog, LYR-8 [(1-((9S)-1-hydroxy-6,6,9-trimethyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-2-yl)ethanone)], as a potent NAG-1 and apoptosis inducer in a panel of human cancer cells. LYR-8 did not possess any affinity for cannabinoid receptor CB(1) or CB(2), which eliminates the concer…

expand abstract